Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,584 USD | +4,03% | +12,08% | +8,61% |
09/05 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
22/03 | Sangamo Therapeutics prijst $24 miljoen Geregistreerd Direct Aanbod | MT |
Omzet 2024 * | 42,83 mln. 39,76 mln. | Omzet 2025 * | 69,73 mln. 64,72 mln. | Marktkapitalisatie | 116 mln. 108 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -98 mln. -90,97 mln. | Nettowinst (verlies) 2025 * | -53 mln. -49,2 mln. | EV/omzet 2024 * | 3,67 x |
Nettoschuld 2024 * | 40,79 mln. 37,86 mln. | Nettoschuld 2025 * | 129 mln. 120 mln. | EV/omzet 2025 * | 3,52 x |
K/w-verhouding 2024 * |
-1,03
x | K/w-verhouding 2025 * |
-2,07
x | Werknemers | 405 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,28% |
Recentste transcriptie over Sangamo Therapeutics, Inc.
1 dag | +7,26% | ||
1 week | +1,01% | ||
Lopende maand | +9,03% | ||
1 maand | +3,31% | ||
3 maanden | -30,26% | ||
6 maanden | +88,96% | ||
Lopend jaar | +3,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01-06-16 |
Director of Finance/CFO | 46 | 01-03-19 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 15-12-22 |
James Meyers
BRD | Director/Board Member | 59 | 22-11-19 |
H. Parker
CHM | Chairman | 68 | 19-06-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
3.66% | 2 M€ | -25,75% | ||
0.49% | 0 M€ | -4,28% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
13-05-24 | 0,59 | +5,09% | 1 310 006 |
10-05-24 | 0,5614 | +7,26% | 4 769 970 |
09-05-24 | 0,5234 | +4,18% | 2 280 030 |
08-05-24 | 0,5024 | -6,95% | 1 572 874 |
07-05-24 | 0,5399 | +2,55% | 1 660 592 |
uitgestelde koers Nasdaq, 10 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,33% | 116 mln. | |
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
-0,26% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,68% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |